The synthesized tumor cells allow scientists to diagnose cancer and optimize treatment without putting the patient through tiresome rigours of chemotherapy trial and error and also minimizes use of expensive stem cells.
Researchers in Japan claim that they have replicated cancer cells from diseased bladder tissue in dogs, minimizing the use of costly stem cell products. The synthesized tumor cells allow scientists to diagnose cancer and optimize treatment without putting the patient through tiresome rigours of chemotherapy trial and error.
The scientists, led by Tatsuya Usui, PhD, DVM, senior assistant professor from the Laboratory of Veterinary Pharmacology at the Tokyo University of Agriculture and Technology, published their findings Establishment of 2.5D culture model using 3D bladder cancer organoid culture inScientific Reports.
Organoids are a niche within the field of 3D bioprinting, which includes a growing stable of chemical and biological processes that generate living tissue for use in research and medical procedures. Clinically viable 3D bioprinting is currently limited to simple structures like a small patch of skin, fat, or cartilage, note the researchers. Ultimately the medical community hopes to generate viable replacement organs, eliminating the need for transplant donors.
Usuis team set out to create a type of organoids without the use of cell-stimulating supplements and Matrigel, a costly product derived from stem cells harvested from genetically engineered rodents. The scarcity of 3D bioprinting products makes them a poor choice for research on a scale that would yield timely cancer diagnoses and new treatments
Three-dimensional (3D) organoid culture holds great promises in cancer precision medicine. However, Matrigel and stem cell-stimulating supplements are necessary for culturing 3D organoid cells. It costs a lot of money and consumes more time and effort compared with 2D cultured cells. Therefore, the establishment of cheaper and Matrigel-free organoid culture that can maintain the characteristics of a part of 3D organoids is demanded,"
In the previous study, we established a dog bladder cancer (BC) 3D organoid culture system by using their urine samples. Here, we successfully isolated cells named 2.5D organoid from multiple strains of dog BC 3D organoids using 2.5 organoid media. The cell proliferation speed of 2.5D organoids was faster than parental 3D organoid cells. The expression pattern of stem cell markers was close to 3D organoids. Injection of 2.5D organoid cells into immunodeficient mice formed tumors and showed the histopathological characteristics of urothelial carcinoma similar to the injection of dog BC 3D organoids.
The 2.5D organoids had a similar sensitivity profile for anti-cancer drug treatment to their parental 3D organoids. These data suggest that our established 2.5D organoid culture method might become a reasonable and useful tool instead of 3D organoids in dog BC research and therapy.
Interestingly, we were able to grow organoid cells using techniques just shy of the traditional, complete 3D bioprinting processa sort of 2.5D processwhile producing most of the 3D organoid features. This means that we could potentially produce cheaper biomaterials for testing and research without jeopardizing much for the accuracy, explained Usui.
Once the team succeeded in creating organoids from the dogs diseased cells, they tested their response to three common anti-cancer drugs as well as several antibodies. They later applied a preservative to the study samples, essentially halting the treatment processes to analyze the results. They also reversed the process, generating 3D organoid cells using traditional bioprinting, then planted them into mice. The cells became tumors as anticipated, giving the team further evidence that 2.5D organoids may be an accurate and effective research medium.
We are confident that our method will make a breakthrough in bladder cancer diagnosis and treatment in both animals and humans, as it efficiently reduces the culture time, handling, gel, and media supplement costs, and therefore it can be an important platform for the development of new bladder cancer therapy, said Usui.
Read more:
Japan Scientists claim to have replicated cancer cells from diseased bladder tissue - BSA bureau
- Advancing Regenerative Medicine: A Comprehensive Outlook on the Global Cell Therapy Market - openPR - March 7th, 2025
- Top 3 Grants in Regenerative Medicine: February 2025 - RegMedNet - March 7th, 2025
- The future of cell therapy: scaling production for global reach - Drug Target Review - March 7th, 2025
- Stem Cell Therapy Repairs Corneal Damage in Trial - Mirage News - March 7th, 2025
- Autologous Cell Therapy Market Anticipated to Hit USD 12.1 Billion by 2031: Persistence Market Research Study - openPR - March 7th, 2025
- Regenerative Therapies Market Forecast to Reach USD 24.41 Billion by 2033 - Persistence Market Research - openPR - March 5th, 2025
- This Japanese Regenerative Medicine Company Just Secured Its Path to NASDAQ Through a $242M Deal - StockTitan - March 5th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - Yahoo - March 5th, 2025
- Animal Stem Cell Therapy Market Forecast to Reach USD 437.3 - openPR - March 3rd, 2025
- A Navy SEALs Journey to Stem Cell Treatment: The Future of Medicine is Here, Just Not in America - SOFREP - March 3rd, 2025
- InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug - Forbes - March 3rd, 2025
- VUMC Part of New Study Validating Curative Therapy for Sickle Cell Disease A - Wgnsradio - March 1st, 2025
- Advancing Stem Cell Therapy and Equity in Patient Care - Targeted Oncology - February 27th, 2025
- How Stem Cell Treatment Reversed A Pro Athlete's Life-threatening Long COVID Disease When all Other treatment Failed - Medical Tourism Magazine - February 27th, 2025
- Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203 - BioSpace - February 27th, 2025
- Bringing Fibroblasts to the Spotlight: Q&A with FibroBiologics - Pharmaceutical Executive - February 27th, 2025
- Mount Sinai-Led Research Team Identifies Underlying Mechanisms of Age-Related Dysfunction in Glands Crucial to Eye Function | Newswise - Newswise - February 25th, 2025
- Experts explore the future of iPSC-based cell therapies - Drug Target Review - February 19th, 2025
- Longeveron Announces World Health Organization Approval of laromestrocel as International Non-proprietary Name for Stem Cell Therapy Lomecel-B -... - February 19th, 2025
- The impact of cytokines on stem cells and organoid research in drug discovery - News-Medical.Net - February 19th, 2025
- Revolutionary FDA-Approved Stem Cell Partnership Puts Adia Med at Forefront of Regenerative Medicine - StockTitan - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - BioSpace - February 19th, 2025
- Bahrain's pioneering use of sickle cell disease treatment hailed by medical experts - The National - February 19th, 2025
- Uganda Treats First Patient Using Stem Cell Therapy - AllAfrica - Top Africa News - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - StreetInsider.com - February 17th, 2025
- Diversity of Cells Allow Colon Cancer to Resist Treatment and To Metastasize - MedicalResearch.com - February 15th, 2025
- Survival outcomes between haploidentical stem cell transplantation and chemotherapy for blastic plasmacytoid dendritic cell neoplasm - Nature.com - February 13th, 2025
- Experimental cell therapy trial treats first Sjgrens disease patient - University of Wisconsin School of Medicine and Public Health - February 11th, 2025
- Stem Cell Therapy Market Types, Applications, Share, Growth - openPR - February 6th, 2025
- Placental Stem Cell Therapy Solution Market Size And Booming - openPR - February 6th, 2025
- Revitalizing Health with Stem Cell Therapy: A Groundbreaking Path To Longevity and Wellness - openPR - February 4th, 2025
- Gene therapy offers new hope for sickle cell disease patients - Open Access Government - February 4th, 2025
- Scientists trial implant to patch up the heart - BBC.com - February 2nd, 2025
- Cell Therapy Market Size is Projected to Reach USD 33.93 - GlobeNewswire - January 28th, 2025
- Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3 - The Medicine Maker - January 28th, 2025
- Immusoft to Present Positive Data from the First Engineered B Cell in a Human Clinical Trial at the 21st Annual WorldSymposium 2025 - The Eastern... - January 28th, 2025
- Beyond the Lab: Stem cell research - Drug Target Review - January 25th, 2025
- Asia Pacific Stem Cell Therapy Market to Reach US$ 4,075.75 Million by 2033 with a Robust CAGR of 10.29% - openPR - January 25th, 2025
- Exciting data: S.Biomedics preps US IND of PD cell therapy - BioWorld Online - January 25th, 2025
- $24.85 Billion Cell Therapy Market Forecast by 2032 (CAGR 20.4%) - openPR - January 25th, 2025
- Stem Cell Therapy Market Expected to Expand at a Steady 2025-2032 - openPR - January 25th, 2025
- Regenerative Medicine Market to receive overwhelming hike US$ 164.9 billion in Revenues by 2032, Growing at a CAGR of 23.30% From 2024 to 2032 -... - January 25th, 2025
- Alternative medicine fans see RFK Jr. as a hero. The fields skeptics worry. - The Washington Post - January 23rd, 2025
- U.S. PRP and Stem Cell Alopecia Treatment Market Analysis 2025-2030 by Treatment, Indication, and End-use - Androgenic Alopecia Dominated the Market... - January 23rd, 2025
- The Future of Regenerative Medicine Lies in the Hands of Chiropractors - Dynamic Chiropractic - January 23rd, 2025
- Stem Cell Therapy Industry Dynamics and Contributions by RTI - openPR - January 21st, 2025
- Stem Cells Market to Reach USD 44.27 Billion by 2033, Driven by Expanding Applications and Innovations - openPR - January 21st, 2025
- Organoids at the Forefront Innovations in Stem Cell Research and Precision Medicine - openPR - January 21st, 2025
- The promising future of regenerative medicine - Yahoo Finance - January 17th, 2025
- An earful of gill: USC Stem Cell study points to the evolutionary origin of the mammalian outer ear - EurekAlert - January 11th, 2025
- Aspen Partners with Mytos to Automate Stem Cell Production for Parkinsons Therapy - Genetic Engineering & Biotechnology News - January 9th, 2025
- School of Medicine professor receives grant to study improved cancer treatments - Mercer University - January 9th, 2025
- Meet CIRM: the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1 - The Medicine Maker - January 7th, 2025
- Regenerative Medicine Market to Experience Significant Growth, Projected to Reach $183.08 Billion by 2031. - openPR - January 7th, 2025
- Stem-cell therapies that work: 10 Breakthrough Technologies 2025 - MIT Technology Review - January 5th, 2025
- 1st stem cell therapy, new HIV drug approved - ecns - January 5th, 2025
- Science fiction turned reality? Stem cell therapy set to repair child's heart - Ynetnews - January 3rd, 2025
- Stem Health Plus Revolutionizes Skin Regeneration with Advanced Stem Cell Skin Graft Technology - The Manila Times - January 1st, 2025
- Allogeneic Stem Cell Transplantation Market Size to Expand Lucratively by 2031 - openPR - January 1st, 2025
- Apoptotic clearance by stem cells: molecular mechanisms for recognition and phagocytosis of dead cells - Nature.com - December 30th, 2024
- Why Medical Tourists are Choosing Mexico: The Affordable Alternative for Advanced Stem Cell Treatments - openPR - December 30th, 2024
- Induced Pluripotent Stem Cells (iPSC) Production Market: Trends, Growth, and the Role of AI - openPR - December 30th, 2024
- Stem cells 'instructed' to form specific tissues and organs - New Atlas - December 28th, 2024
- Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia - Medpage Today - December 28th, 2024
- Black Group Investment Partners with Zenzic Oasis to Advance Stem Cell Therapy for Personalised Medicine - Galveston County Daily News - December 28th, 2024
- Black Group Investment Partners with Zenzic Oasis to Advance Stem Cell Therapy for Personalised Medicine - Voice Of Alexandria - December 28th, 2024
- U.S. Stem Cell Therapy Market Revenue to Attain USD 17.70 Bn by 2033 - Precedence Research - December 27th, 2024
- Here are some biggest medical breakthroughs of 2024 - Medical Buyer - December 27th, 2024
- Researchers from Korea University explore how ascorbic acid and FGF4 revolutionize regenerative medicine - EurekAlert - December 27th, 2024
- Regenerative Medicine Market to Skyrocket to USD 73,084.2 Million by 2033 at a 18.5% of CAGR - openPR - December 27th, 2024
- Stem cell therapy to correct heart failure in children could 'transform lives' - Fox News - December 25th, 2024
- Advancing type 1 diabetes therapy: autologous islet transplant breakthrough - Nature.com - December 25th, 2024
- Stem Cell Therapy Market to Triple in Value, Reaching USD 52.1 Billion by 2034 at a 12.1% of CAGR - openPR - December 25th, 2024
- Stem-cell therapies: A breakthrough in treating parkinson's, cancer, diabetes, and more - The Business Standard - December 25th, 2024
- Replay 2024 : 6 Biggest Medical Breakthroughs Of 2024 - NewsX - December 25th, 2024
- Tumbling stem cells? Watch how movement plays a part in their fate - Scope - December 20th, 2024
- SCD patients free of VOEs after treatment with gene-editing therapy - Sickle Cell Disease News - December 20th, 2024
- Japan's Sumitomo to establish regenerative medicine and cell therapy joint venture - BSA bureau - December 20th, 2024
- Brain cells remain healthy after a month on the International Space Station, but mature faster than brain cells on Earth - EurekAlert - December 19th, 2024
- Reindeers Pave the Way for Regenerative Medicine - The Scientist - December 19th, 2024
Recent Comments